Analysis of antimicrobial peptides from extreme environments reveals potential against bacterial infections, suggesting applications in antimicrobial resistance.
Background Antimicrobial peptides (AMPs) inhibit microbial growth through membrane disruption or interference with intracellular processes, offering promising solutions to antimicrobial resistance (AMR). While AMPs have been extensively identified and verified from animal proteomes, reference microbial genomes and host environments, those from extreme habitats remain largely unexplored. Microbes in such extreme niches with low-level of nutrients evolve unique membrane modification and specialized metabolic pathway, representing a hidden reservoir for novel AMP discovery. Methods We developed Atlantis, a language model-driven framework for AMP detection and optimization from global extremophile (Fig. 1). It combined two modules: Atlantis-Prospect, which predict antimicrobial potency based on both sequence and structure information, and Atlantis-Search, which conducts iterative single-mutations with structural constraints to broaden peptides’ antimicrobial activity from narrow to broad spectrum. The pretrained structure-aware language model was fine-tuned on small proteins from extremophile to capture biome-specific evolutionary information. Results By mining 60,461 extremophile metagenomes from nine discrete habitats across multiple geographical scales, we identified 1662 non-redundant peptides with potential antimicrobial activity from 85 bacterial and archaeal phyla, none of which match existing databases. We synthesized fourteen peptides, and two of them showed stronger antimicrobial activity then commercial AMP, LL-37, in vitro against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus (Fig. 2).
No takes yet. Share an insight, caveat, or question.
Kang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: